Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1205192.RA1ysATNOVrNnBSY7t3BLY8fyKym--br0XZvbd2w4Nrw4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1205192.RA1ysATNOVrNnBSY7t3BLY8fyKym--br0XZvbd2w4Nrw4130_assertion type Assertion NP1205192.RA1ysATNOVrNnBSY7t3BLY8fyKym--br0XZvbd2w4Nrw4130_head.
- NP1205192.RA1ysATNOVrNnBSY7t3BLY8fyKym--br0XZvbd2w4Nrw4130_assertion description "[High expression of Nur77 was observed in clinical CRC tissues, and this elevated expression was significantly associated with advanced tumor, lymph nodes, distant metastasis stage (P = 0.003), lymph node metastasis (P = 0.001) and poor survival (P = 0.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1205192.RA1ysATNOVrNnBSY7t3BLY8fyKym--br0XZvbd2w4Nrw4130_provenance.
- NP1205192.RA1ysATNOVrNnBSY7t3BLY8fyKym--br0XZvbd2w4Nrw4130_assertion evidence source_evidence_literature NP1205192.RA1ysATNOVrNnBSY7t3BLY8fyKym--br0XZvbd2w4Nrw4130_provenance.
- NP1205192.RA1ysATNOVrNnBSY7t3BLY8fyKym--br0XZvbd2w4Nrw4130_assertion SIO_000772 25064356 NP1205192.RA1ysATNOVrNnBSY7t3BLY8fyKym--br0XZvbd2w4Nrw4130_provenance.
- NP1205192.RA1ysATNOVrNnBSY7t3BLY8fyKym--br0XZvbd2w4Nrw4130_assertion wasDerivedFrom befree-2016 NP1205192.RA1ysATNOVrNnBSY7t3BLY8fyKym--br0XZvbd2w4Nrw4130_provenance.
- NP1205192.RA1ysATNOVrNnBSY7t3BLY8fyKym--br0XZvbd2w4Nrw4130_assertion wasGeneratedBy ECO_0000203 NP1205192.RA1ysATNOVrNnBSY7t3BLY8fyKym--br0XZvbd2w4Nrw4130_provenance.